The Board of directors of J.B. Chemicals & Pharmaceuticals Ltd. ("Company"), at its meeting held on October 5, 2020 ("Appointment Date"), has appointed Mr. Nikhil Chopra as Whole-time Director and Chief Executive Officer of the Company for a period of five (5) years from the Appointment Date. This appointment is subject to approval by the members of the Company at next general meeting. Prior to joining the Company, Mr. Nikhil Chopra worked as Head-India Business at Cipla Limited.
Mr. Nikhil Chopra 47, is a Business leader with over 20 years of experience backed up with consistent record of sustainable growth and shareholder value creation. For over two decades, he has spearheaded breakthrough ideas focused on creating greater access to high quality treatment & medicines, and gain a significant competitive advantage over peers, especially in therapies such as Respiratory, Urology HIV and Paediatric Care.
Healthcare / Pharmaceuticals / Health Technology / Public Health
- Led and managed diversified boards, teams and cross functions to drive business outcomes as aligned with strategic growth plans
- Been at the forefront of innovation by kick-starting 'Beyond the Pill' & "Direct to Consumer" initiatives in Indian pharmaceutical industry
- Incubated new revenue generating platforms in diagnostic services and digital therapeutics
- Led strategic partnerships with innovator companies for patented medicines and new drug delivery systems, thereby expanding footprint in therapies such as Cardiology, Diabetes and Oncology
- Driven mass scale Digital Transformation for field force as well as HCP engagements
- Spearheaded implementation for the largest Patient Support Program in the field of Respiratory which ensures more than 2 million patient touchpoints every year
- Strong track record in driving cross functional collaboration and nurturing talent to own up higher responsibilities across functions
He holds M.Sc. (Organic Chemistry) from Gujarat University.
Shares of J.B.CHEMICALS & PHARMACEUTICALS LTD. was last trading in BSE at Rs.975.15 as compared to the previous close of Rs. 991.55. The total number of shares traded during the day was 13059 in over 1830 trades.
The stock hit an intraday high of Rs. 1008 and intraday low of 973. The net turnover during the day was Rs. 12930766.